Joint debridement for haemophilic arthropathy of the knee
β Scribed by E. C. Rodriguez Merchan; M. Magallon; E. Galindo
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 1021 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0341-2695
No coin nor oath required. For personal study only.
β¦ Synopsis
Joint debridement was performed for advanced haemophilic arthropathy of the knee in eleven patients. Follow up was for an average of 5.4 years and the results were evaluated retrospectively by the Hospital for Special Surgery disability score sheet. The clinical results were excellent in fore; good in five and fair in two. Debridement should be considered in the young haemophiliac to avoid, or delay, total knee arthroplasty. The operation may give the patient years of life without pain and it appears to slow the development of radiographic changes. R 6 s u m C Les auteurs prdsentent les r~sultats de onze interventions de nettoyage du genou avec remodelage, rdalis~es au cours d'une p~riode de 15 ans. L'gtge moyen des himophiles au moment de l'opdration dtait de 28 ans, le recul moyen des observations est de 5.4 ans. Les Msultats cliniques ont dt~ dvaluds selon la cotation HSS: quatre sont excellents, cinq bons et deux midiocres. Ces Msultats montrent que le nettoyage du genou des hdmophiles constitue un traitement efficace des articulations douloureuses avec d~t~rioration radiologique avancge. Il peut ralentir le cours naturel de l'gvolution et retarder la n~cessitd d'une arthroplastie totale du genou chez le jeune hdmophile.
π SIMILAR VOLUMES
A prospective review of 254 patients with moderate or severe knee pain due to degenerative joint disease, treated by arthroscopic debridement of menisci, articular cartilage, osteophytes and loose bodies has been made 24 to 140 months (average of 44 months) after surgery. Patients ranged in age from
A new operative technique in arthroscopic treatment of chondromalacia using ultraviolet laser systems is introduced. The postoperative results are evaluated in a prospective and randomized clinical trial. One hundred and forty patients stage II or III chondromalacia according to Outerbridge were ran